wherein each among R1 and R2 represents (C1-C6)-alkyl group optionally substituted with halogen atoms and so on; each among R3, R4 and R5 represents hydrogen atom, halogen atom and so on, either R3 and R4 in common with carbon atoms bound to them can form a carbocyclic or heterocyclic ring optionally having a substitute (substitutes); A represents -N(R7)(R8) and so on; ring B represents aryl group or heterocyclic residue; R6 represents hydrogen atom, halogen atom, (C1-C6)-alkyl group and so on; n means a whole number from 1 to 3, or its pharmaceutically acceptable salt. Proposed compounds elicit the selective and strong inhibitory effect on CETP activity and can be used as therapeutic or prophylactic agents against hyperlipidemia or arteriosclerosis. Also, the proposed compound can be used with other pharmaceutical agent or some pharmaceutical agents simultaneously against hyperlipidemia or arteriosclerosis. Invention provides the development of a pharmaceutical composition based on dibenzylamine compounds used in treatment or prophylaxis of hyperlipidemia or arteriosclerosis.;EFFECT: valuable medicinal properties of compound and pharmaceutical composition.;25 cl, 40 tbl, 174 ex"/> DIBENZYLAMINE COMPOUNDS, PHARMACEUTICAL COMPOSITION AND THERAPEUTIC OR PROPHYLACTIC AGENT BASED ON THEREOF, METHOD FOR TREATMENT OR PROPHYLAXIS OF HYPERLIPIDEMIA OR ARTERIOSCLEROSIS
首页> 外国专利> DIBENZYLAMINE COMPOUNDS, PHARMACEUTICAL COMPOSITION AND THERAPEUTIC OR PROPHYLACTIC AGENT BASED ON THEREOF, METHOD FOR TREATMENT OR PROPHYLAXIS OF HYPERLIPIDEMIA OR ARTERIOSCLEROSIS

DIBENZYLAMINE COMPOUNDS, PHARMACEUTICAL COMPOSITION AND THERAPEUTIC OR PROPHYLACTIC AGENT BASED ON THEREOF, METHOD FOR TREATMENT OR PROPHYLAXIS OF HYPERLIPIDEMIA OR ARTERIOSCLEROSIS

机译:二苯甲酰胺化合物,基于其的药物组合物和治疗性或预防性药物,高脂血症或动脉硬化的治疗或预防方法

摘要

FIELD: organic chemistry, medicine, pharmacy.;SUBSTANCE: invention relates to dibenzylamine compounds of the formula (1): wherein each among R1 and R2 represents (C1-C6)-alkyl group optionally substituted with halogen atoms and so on; each among R3, R4 and R5 represents hydrogen atom, halogen atom and so on, either R3 and R4 in common with carbon atoms bound to them can form a carbocyclic or heterocyclic ring optionally having a substitute (substitutes); A represents -N(R7)(R8) and so on; ring B represents aryl group or heterocyclic residue; R6 represents hydrogen atom, halogen atom, (C1-C6)-alkyl group and so on; n means a whole number from 1 to 3, or its pharmaceutically acceptable salt. Proposed compounds elicit the selective and strong inhibitory effect on CETP activity and can be used as therapeutic or prophylactic agents against hyperlipidemia or arteriosclerosis. Also, the proposed compound can be used with other pharmaceutical agent or some pharmaceutical agents simultaneously against hyperlipidemia or arteriosclerosis. Invention provides the development of a pharmaceutical composition based on dibenzylamine compounds used in treatment or prophylaxis of hyperlipidemia or arteriosclerosis.;EFFECT: valuable medicinal properties of compound and pharmaceutical composition.;25 cl, 40 tbl, 174 ex
机译:技术领域本发明涉及式(1)的二苄胺化合物:<图像文件=“ 00000002.GIF” he =“ 60” imgContent =“ undefined” imgFormat =“ GIF” wi = “ 72” />其中R 1 和R 2 中的每一个代表(C 1 -C 6 )-任选地被卤素原子取代的烷基等; R 3 ,R 4 和R 5 中的每一个代表氢原子,卤素原子等,R 3 和R 4 与键合到它们上的碳原子相同,可以形成一个碳环或杂环,可选地具有取代基(取代基); A代表-N(R 7 )(R 8 ),依此类推;环B代表芳基或杂环残基; R 6 代表氢原子,卤素原子,(C 1 -C 6 )-烷基等。 n表示1至3的整数或其药学上可接受的盐。所提出的化合物引起对CETP活性的选择性和强抑制作用,并且可以用作针对高脂血症或动脉硬化的治疗剂或预防剂。而且,提出的化合物可以与其他药剂或某些药剂同时用于抗高脂血症或动脉硬化。本发明提供了基于二苄胺化合物的药物组合物的开发,该药物组合物用于治疗或预防高脂血症或动脉硬化。效果:该化合物和药物组合物的有价值的医学特性; 25 cl,40 tbl,174

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号